Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

NCT00999947 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 351

Last updated 2013-11-25

No results posted yet for this study

Summary

The purpose of this trial is to study the genetic and phenotypic aspects of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C), and determine the impact of genetic testing in clinical practice.

Conditions

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Philippe Charron, MD, PhD · Pitié-Salpêtrière Hospital

Eligibility

Min Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2013-03-31
Completion
2013-03-31

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00999947 on ClinicalTrials.gov